Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab

American Journal of Hematology

Volumn 78, Issue 2, 2005, Pages 123-126

  Ramanathan, S ^a   Koutts, J ^a   Hertzberg, Mark S ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Autoimmune; Hemolysis; Rituximab; Warm antibody

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENOXAPARIN; FOLIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISOLONE; RITUXIMAB;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; REFRACTORY WARM AUTOIMMUNE HEMOLYTIC ANEMIA; REMISSION; SPLENECTOMY; THROMBOCYTOPENIA;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; FEMALE; HEAT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 13244292388     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20220     Document Type: Article

References (27)

1. Dacie J. The immune haemolytic anemias: a century of exciting progress in understanding. Br J Haematol 2001;114:770-785.
2. Petz LD. Treatment of autoimmune haemolytic anemias. Curr Opin Haematol 2001;8:411-416.
3. Edwards JCW, Leandro MJ, Cambridge G. B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders. Biochem Soc Trans 2002;30(4):824-828.
4. Berentsen S, Tjonnfjord GE, Brudevold R, et al. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol 2001;115:79-83.
5. Gharib M, Poynton C. Complete, long-term remission of refractory idiopathic cold haemagglutinin disease after mabthera. Br J Haematol 2002;117:248-249.
6. Pulik M, Genet P, Lionnet F, Touahri T. Treatment of primary chronic cold agglutinin disease with rituximab: maintenance therapy may improve results. Br J Haematol 2002;117:998-999.
7. Mori A, Tamaru J-I, Sumi H, Kondo H. Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy. Eur J Haematol 2002;68:243-246.
8. Zaja F, Iacona I, Masolini P, et al. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica 2002;87:189-195.
9. Delgado J, Bustos JG, Jimenez-Yuste V, Hernandez-Navarro F. Anti CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura. Haematologica 2002;87:215-216.
10. Muwakitt S, Locatelli F, Abboud M, Razzouk B, Wilimas J. Report of a child with vitiligo and Evans syndrome. J Paediatr Haematol/Oncol 2003;25(4):344-345.
11. Grossi A, Santini V, Longo G, Balestri F, Rossini Ferrini P. Treatment with anti CD20 antibodies of patients with autoimmune thrombocytopenia with or without haemolytic anemia: worsening in haemoglobin level. Blood 2000;96:1089a (abstract).
12. Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti CD20 monoclonal antibody for adults with chronic idiopathic thrombocytopenia purpura. Blood 2001;98:952-957.
13. Lee E, Zamkoff KW, Gentile TC, Zimrin A. Rituxan in the treatment of autoimmune haemolytic anemia (AIHA). Blood 2000;96(Suppl 1):596a (abstract).
14. Zecca M, De Stefano P, Nobili B, Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and haemolytic anemia. Blood 2001;97:3995-3997.
15. Morselli M, Luppi M, Potenza L, et al. Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment. Blood 2002;99:3478-3479.
16. Ahrens N, Kingreen D, Seltsam A, Salama A. Treatment of refractory autoimmune haemolytic anaemia with anti CD20 (rituximab). Br J Haematol 2001;114:244-245.
17. Shanafelt TD, Madeueme HL, Wolf RC, Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc 2003;78(11):1340-1346.
18. Kerridge I, Hann I, Ethel M, Potter M, Prentice HG. Anti-CD20 monoclonal antibody (rituximab) therapy in a child with refractory chronic autoimmune haemolytic anaemia. Intern Med J 2003;33:544.
19. McMahon C, Babu L, Hodgson A, Hayat A, Connell NO, Smith OP. Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)? Br J Haematol 2002;117:480-482.
20. Quartier P, Brethon B, Phillippet P, Landman-Parker J, Le Deist F, Fischer A. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001;358:1511-1513.
21. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101:3857-3861.
22. Motto DG, Williams JA, Boxer LA. Rituximab for refractory childhood autoimmune hemolytic anemia. Isr Med Assoc J 2002;4:1006-1008.
23. Webster D, Ritchie B, Mant MJ. Prompt response to rituximab of severe hemolytic anemia with both cold and warm antibodies. Am J Hematol 2004;75:258-259.
24. Galor A, O'Brien T. Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome. Int J Hematol 2003;78:335-336.
25. Gupta N, Kavuru S, Patel D, et al. Rituximab based chemotherapy for steroid refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia 2002;16:2092-2095.
26. Trape G, Fianchi L, Lai M, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. Haematologica 2003;88(2):223-225.
27. Finazzi G. Rituximab in autoimmune cytopenias: for which patients? Haematologica 2002;87:113-116.